These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20220087)

  • 21. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
    Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV; Sylvester PW
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer.
    Zhao C; Tao T; Yang L; Qin Q; Wang Y; Liu H; Song R; Yang X; Wang Q; Gu S; Xiong Y; Zhao D; Wang S; Feng D; Jiang WG; Zhang J; He J
    Cancer Lett; 2019 Jul; 453():107-121. PubMed ID: 30930234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
    Tang LL; Yokoyama Y; Wan X; Iwagaki S; Niwa K; Tamaya T
    Oncol Rep; 2006 Apr; 15(4):855-9. PubMed ID: 16525671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
    Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
    Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
    Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
    Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F
    Cancer Res; 2004 Apr; 64(8):2858-64. PubMed ID: 15087404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins.
    Quaglino E; Mastini C; Amici A; Marchini C; Iezzi M; Lanzardo S; De Giovanni C; Montani M; Lollini PL; Masucci G; Forni G; Cavallo F
    Cancer Res; 2010 Apr; 70(7):2604-12. PubMed ID: 20332241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TIMAP promotes angiogenesis by suppressing PTEN-mediated Akt inhibition in human glomerular endothelial cells.
    Obeidat M; Li L; Ballermann BJ
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F623-33. PubMed ID: 25007873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint.
    Xue L; Chiang L; Kang C; Winoto A
    Eur J Immunol; 2008 Nov; 38(11):3200-7. PubMed ID: 18991293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
    Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.
    Riggio M; Polo ML; Blaustein M; Colman-Lerner A; Lüthy I; Lanari C; Novaro V
    Carcinogenesis; 2012 Mar; 33(3):509-18. PubMed ID: 22180571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation.
    Guijarro MV; Link W; Rosado A; Leal JF; Carnero A
    Carcinogenesis; 2007 Dec; 28(12):2443-50. PubMed ID: 17675338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibition.
    Goltsov A; Faratian D; Langdon SP; Bown J; Goryanin I; Harrison DJ
    Cell Signal; 2011 Feb; 23(2):407-16. PubMed ID: 20951800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector.
    Gallo P; Dharmapuri S; Nuzzo M; Maldini D; Iezzi M; Cavallo F; Musiani P; Forni G; Monaci P
    Int J Cancer; 2005 Jan; 113(1):67-77. PubMed ID: 15386429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.
    Quaglino E; Mastini C; Iezzi M; Forni G; Musiani P; Klapper LN; Hardy B; Cavallo F
    Vaccine; 2005 May; 23(25):3280-7. PubMed ID: 15837233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.
    Jacob J; Radkevich O; Forni G; Zielinski J; Shim D; Jones RF; Wei WZ
    Cell Immunol; 2006 Apr; 240(2):96-106. PubMed ID: 16930573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.